NuVasive faces setback over reimbursement of surgical procedure

12/1/2009 | CNBC

Aetna, Cigna and UnitedHealth Group will not pay surgeons who use NuVasive's XLIF spinal surgery after they classified the procedure as "experimental." NuVasive said it is working to reverse the health insurers' recommendation, and doctors are still receiving payments at local and regional levels.

View Full Article in:

CNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health